January 16, 2010 3:20 PM Subscribe
For the patent lawyers in the house... If a pharmaceutical company creates a me-too drug, (i.e. a drug that offers no improvement over the existing drug in its class--for instance claritin, allegra, zyrtec, etc.) is their burden of proof in the patent process that their drug is "better than placebo" or that it is "as good as the pre-existing drug in the class?"